Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgical Resection Margin According to the Post-treatment Tumor Volume Versus the Pre-treatment Tumor Volume in Breast Conservative Surgery for Invasive Breast Cancer Patients Receiving Primary Systemic Therapy: Randomized Controlled Trial

NCT03417622 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03417622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03417622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgical Resection Margin According to the Post-treatment Tumor Volume Versus the Pre-treatment Tumor Volume in Breast Conservative Surgery for Invasive Breast Cancer Patients Receiving Primary Systemic Therapy: Randomized Controlled Trial
Lead sponsor
Mansoura University
Phase
Phase 3
Overall status
Unknown status
Start date
August 1, 2019
Completion date
August 1, 2026
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer